Consistent evidence of numerous studies substantiates the asleep blood pressure (BP) mean derived from ambulatory BP monitoring (ABPM) is both an independent and a stronger predictor of cardiovascular disease (CVD) risk than are daytime clinic BP measurements or the ABPM-determined awake or 24-hour BP means. Hence, cost-effective adequate control of sleep-time BP is of marked clinical relevance. Ingestion time, according to circadian rhythms, of hypertension medications of 6 different classes and their combinations significantly improves BP control, particularly sleep-time BP, and reduces adverse effects.
Keywords: Ambulatory blood pressure monitoring; Asleep blood pressure; Cardiovascular risk; Chronic kidney disease; Diabetes; Hygia project; Hypertension chronotherapy; Resistant hypertension.
Copyright © 2017 Elsevier Inc. All rights reserved.